Compounds > dydrogesterone
Page last updated: 2024-08-20

dydrogesterone and Hot Flashes

dydrogesterone has been researched along with Hot Flashes in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Gu, L; Kahler, E; Pexman-Fieth, C; Ren, M; Ruan, X; Yu, Q1
Durand, G; Kahler, E; Pertyński, T; Stevenson, JC1
Chrystyn, H; Elfituri, A; Elmahaishi, M; Sherif, F1
Bakowski, M; Cieraad, D; Conradt, C; Jesinger, D1
Cobellis, L; Colacurci, N; De Franciscis, P; Fornaro, F; Sepe, E; Torella, M1
Cacciatore, B; Hirvonen, E; Rita, H; Wahlström, T; Wilén-Rosenqvist, G1

Trials

6 trial(s) available for dydrogesterone and Hot Flashes

ArticleYear
Ultra-low-dose estradiol and dydrogesterone: a phase III study for vasomotor symptoms in China.
    Climacteric : the journal of the International Menopause Society, 2022, Volume: 25, Issue:3

    Topics: Double-Blind Method; Dydrogesterone; Estradiol; Female; Hot Flashes; Humans; Quality of Life

2022
Oral ultra-low dose continuous combined hormone replacement therapy with 0.5 mg 17β-oestradiol and 2.5 mg dydrogesterone for the treatment of vasomotor symptoms: results from a double-blind, controlled study.
    Maturitas, 2010, Volume: 67, Issue:3

    Topics: Administration, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Middle Aged; Postmenopause; Quality of Life; Treatment Outcome; Vasomotor System

2010
Two hormone replacement therapy (HRT) regimens for middle-eastern postmenopausal women.
    Maturitas, 2005, Sep-16, Volume: 52, Issue:1

    Topics: Administration, Oral; Adult; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Libya; Longitudinal Studies; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies; Severity of Illness Index; Treatment Outcome; White People

2005
Clinical study comparing the effects of sequential hormone replacement therapy with oestradiol/dydrogesterone and conjugated equine oestrogen/norgestrel on lipids and symptoms.
    Archives of gynecology and obstetrics, 2006, Volume: 274, Issue:2

    Topics: Cholesterol, HDL; Double-Blind Method; Drug Therapy, Combination; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Middle Aged; Norgestrel; Perimenopause; Postmenopause; Prospective Studies; Vasomotor System

2006
Low-dose hormone therapy in the perimenopause.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2007, Volume: 98, Issue:2

    Topics: Dose-Response Relationship, Drug; Drug Combinations; Dydrogesterone; Estradiol; Female; Hormone Replacement Therapy; Hot Flashes; Humans; Menorrhagia; Middle Aged; Perimenopause; Progesterone Congeners; Prospective Studies

2007
Effects of transdermal oestrogen therapy in postmenopausal women: a comparative study of an oestradiol gel and an oestradiol delivering patch.
    British journal of obstetrics and gynaecology, 1997, Volume: 104 Suppl 16

    Topics: Administration, Cutaneous; Aged; Bone Density; Drug Therapy, Combination; Dydrogesterone; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrone; Female; Gels; Hot Flashes; Humans; Middle Aged; Patient Satisfaction; Progesterone Congeners; Uterine Hemorrhage

1997